Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 0.0 | BCD100427B02 | 5.43 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 0.5 | BCD100427B05 | 6.23 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 1.0 | BCD100427B09 | - | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 2.0 | BCD100427B13 | 7.23 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 4.0 | BCD100427B17 | 4.05 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 8.0 | BCD100427B21 | 3.2 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 12.0 | BCD100427B25 | 2.56 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 24.0 | BCD100427B29 | 1.85 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 0.0 | BCD100427B01 | 2.82 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 0.5 | BCD100427B03 | 5.1 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 1.0 | BCD100427B07 | 3.25 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 2.0 | BCD100427B11 | 3.06 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 4.0 | BCD100427B15 | 3.07 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 8.0 | BCD100427B19 | 2.49 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 12.0 | BCD100427B23 | 6.09 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 24.0 | BCD100427B27 | 1.58 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B06 | 4.21 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B10 | 4.1 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B14 | 5.9 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B18 | - | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B22 | 12.4 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B26 | 23 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B30 | 40.6 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 0.5 | BCD100427B04 | 2.78 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 1.0 | BCD100427B08 | 4.37 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 2.0 | BCD100427B12 | 6.13 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 4.0 | BCD100427B16 | - | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 8.0 | BCD100427B20 | 15.5 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 12.0 | BCD100427B24 | 13.1 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 24.0 | BCD100427B28 | 12.5 | pmol/sample |